Double-blind crossoer clinical trial of pyridinolcarbamate in peripheral arterial disease (arteriosclerosis obliterans).

This publication has 14 references indexed in Scilit:

• Clinical trial of methyl clofenapate (A derivative of clofibrate) in patients with essential hyperlipidaemias: With special reference to type II (primary) hyperlipidaemia
  Atherosclerosis, 1972
• Clinical pharmacologic evaluation of the antiatherosclerotic agent, pyridinolcarbamate. A double-blind crossover trial in the treatment of atherosclerosis obliterans
  American Heart Journal, 1970
• The Natural Course of Peripheral Arteriosclerosis Obliterans Evaluated By Flow Measurements
  Angiology, 1969
• Serial aortography in the study of peripheral vascular disease—a clinical-radiological study
  The British Journal of Radiology, 1968
• Thymic permeability factor: Its relationship to lymph‐node permeability factor and its antagonism by pyridinol carbamate (Anginin) and other anti‐inflammatory agents
  The Journal of Pathology and Bacteriology, 1967
• The Effects of Hyperosmolarity on Intact and Isolated Vascular Smooth Muscle. Possible Role in Exercise Hyperemia
  Journal of Vascular Research, 1967
• The natural history of atherosclerosis: Comparison of aortic lesions in Tokyo, New Orleans, Guatemala and Costa Rica
  Journal of Atherosclerosis Research, 1966
• Pyridinolcarbamate, a bradykinin antagonist in veins: A preliminary report on pharmacologic and clinical observations
  American Heart Journal, 1966
• AORTOGRAPHY IN THE INVESTIGATION OF HYPERTENSION
  The Lancet, 1965
• PROGNOSIS IN ARTERIOSCLEROTIC PERIPHERAL VASCULAR DISEASE
  JAMA, 1958